期刊文献+

叶酸联合B族维生素治疗HHcy血症脑梗死的疗效观察 被引量:2

下载PDF
导出
摘要 目的观察叶酸和B族维生素联合治疗高同型半胱氨酸(HHcy)血症脑梗死的疗效。方法 2012-03—2013-07我院HHcy血症脑梗死患者随机分为治疗组和对照组。对照组给予复方丹参注射液30mL加入5%GS 250mL静滴,1次/d;拜阿司匹林100mg口服,1次/d;维生素B12 500μg及维生素B10.1g肌注,1次/d;维生素B6片10mg口服,3次/d。治疗组在对照组基础上给予叶酸片5mg口服,1次/d。疗程均为4周。治疗前后分别测定各组患者血浆Hcy(同型半胱氨酸)浓度。结果治疗组血浆同型半胱氨酸浓度较对照组明显改善,差异有统计学意义(P<0.05)。结论叶酸和B族维生素联合治疗能有效降低血同型半胱氨酸水平,改善脑梗死患者的预后。
出处 《中国实用神经疾病杂志》 2015年第23期117-117,共1页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献2

二级参考文献16

  • 1李振英,朱惠萍,刘力,梁琳琳.同型半胱氨酸与脑血管病相关因素分析[J].临床神经病学杂志,2006,19(1):37-37. 被引量:19
  • 2高娟,高莉梅,王景艳,郭力.高同型半胱氨酸血症及其相关因素与青年脑梗死的关系[J].脑与神经疾病杂志,2007,15(1):49-51. 被引量:22
  • 3Vermeulen EG,Stehouwer CD,Valk J,et al.Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI:a placebo -controlled,randomized trial[J].Eur J Clin Invest,2004,34(4):256-261.
  • 4Vermeulen EG,Stehouwer CD,Twisk JW,et al.Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis:a randomised,placebo-controlled trial[J].Lancet,2000,355(9203):517-522.
  • 5Zhang C,Cai Y,Adachi MT,et al.Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response[J].J Biol Chem,2001,276(38):35867-35874.
  • 6Wang H,Yoshizumi M,Lai K,et al.Inhibition of growth and p21 ras methylation in vascular endothelial cells by homocysteine but not cysteine[J].J Biol Chem,1997,272(40):25380-25385.
  • 7Guenther BD,Sheppard CA,Tran P,et al.The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia[J].Nat Struct Biol,1999,6(4):359-365.
  • 8Ribo M,Montaner J,Monasterio J,et al.Role of homocysteine in the acute phase of stroke[J]. Neurologia,2004,19:10.
  • 9Diaz A.Homocysteine and neurologic disease[J].Arch Neurol, 2000, 57:1422.
  • 10Dusitanond P,Eikelboom JW,Hankey GJ,et al. Homocystienelowering treatment with folic acid,cobalamin,and phyridoxine does not reduce blood markers of inflammation,endothelial dysfunction,or hypercoagulability in patients with previous transient ischemic attack or stroke:A randomized substudy of the VITATOPS trial[J]. Stroke, 2005,36:144.

共引文献32

同被引文献16

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部